1. Analiza tveganja uvedbe detajlističnih ambulant v SlovenijiMaja Trošt, 2008, undergraduate thesis Keywords: Slovenija, zdravstvo, zdravstveno varstvo, zavarovanje, podjetje, nakupovalni centri, tržna analiza, planiranje, kadri, konkurenca, analiza
Full text (outside link) |
2. Analiza napovednih indikatorjev slovenskega bruto domačega proizvodaMaja Trošt, 2011, master's thesis Keywords: Slovenija, gospodarska gibanja, ekonomski razvoj, ekonomska rast, bruto domači proizvod, ekonomska predvidevanja, indikatorji, časovne vrste, modeli
Full text (outside link) |
3. Serotonin-related functional genetic variants affect the occurrence of psychiatric and motor adverse events of dopaminergic treatment in Parkinson’s diseaseSara Redenšek Trampuž, Tanja Blagus, Maja Trošt, Vita Dolžan, 2022, original scientific article Keywords: Parkinson’s disease, motor complications, visual hallucinations, impulse control disorders, dyskinesia, polymorphism, serotonin, adverse event, pharmacogenomics
Full text (file, 550,02 KB) This document has more files! More... |
4. Sporadic Creutzfeldt–Jakob disease is associated with reorganization of metabolic connectivity in a pathological brain networkTomaž Rus, Jernej Mlakar, Luka Ležaič, An Vo, Nha Nguyen, Chris Chengke Tang, Michele Fiorini, Elena Prieto, Gloria Martí Andrés, Javier Arbizu, David Eidelberg, Maja Trošt, 2023, original scientific article Keywords: brain networks, Creutzfeldt–Jakob disease, Creutzfeldt–Jakob disease-related pattern, FDG-PET, graph theory
Full text (file, 16,12 MB) This document has more files! More... |
5. Switching and combining device-aided therapies in advanced Parkinson’s diseaseDejan Georgiev, Sentilija Delalić, Nina Zupančič-Križnar, Achinoam Socher, Tanya Gurevich, Maja Trošt, 2022, original scientific article Keywords: advanced Parkinson’s disease, deep brain stimulation of the subthalamic nucleus, L-dopa/carbidopa intestinal gel infusion, continuous subcutaneous apomorphine infusion
Full text (file, 1020,95 KB) This document has more files! More... |
6. Clinical and clinical-pharmacogenetic models for prediction of the most common psychiatric complications due to dopamingeric treatment in Parkinson's diseaseSara Redenšek Trampuž, Barbara Jenko Bizjan, Maja Trošt, Vita Dolžan, 2020, original scientific article Keywords: Parkinson's disease, polymorphism, pharmacogenetics, impulse control disorders, predictive model, psychiatric complications, visual hallucinations
Full text (file, 3,37 MB) This document has more files! More... |
7. Genetic variability of inflammation and oxidative stress genes does not play a major role in the occurrence of adverse events of dopaminergic treatment in Parkinson's diseaseSara Redenšek Trampuž, Dušan Flisar, Maja Kojović, Milica Gregorič Kramberger, Dejan Georgiev, Zvezdan Pirtošek, Maja Trošt, Vita Dolžan, 2019, original scientific article Keywords: Parkinson's disease, susceptibility, polymorphism, inflammation, oxidative stress, adverse events
Full text (file, 673,75 KB) This document has more files! More... |
8. Dopaminergic pathway genes influence adverse events related to dopaminergic treatment in Parkinson's diseaseSara Redenšek Trampuž, Dušan Flisar, Maja Kojović, Milica Gregorič Kramberger, Dejan Georgiev, Zvezdan Pirtošek, Maja Trošt, Vita Dolžan, 2019, original scientific article Keywords: Parkinson's disease, genetic polymorphism, dopaminergic pathway, personalized medicine, adverse events
Full text (file, 411,70 KB) This document has more files! More... |
|
10. Adverse effects of levodopa/carbidopa intrajejunal gel treatmentTomaž Rus, Maša Premzl, Nina Zupančič-Križnar, Milica Gregorič Kramberger, Robert Rajnar, Lidija Ocepek, Zvezdan Pirtošek, Maja Trošt, 2022, original scientific article Keywords: advanced Parkinson's disease, levodopa-carbidopa intestinal gel, percutaneous endoscopic gastrojejunostomy, adverse effects, health-related quality of life
Full text (file, 1,14 MB) This document has more files! More... |
